Dennis Hensen has been named director of the Biological Process Development Facility in the College of Engineering, beginning September 2021. He also serves as the project management lead for the facility.
The Biological Process Development Facility (BPDF) at the University of Nebraska-Lincoln offers biopharmaceutical process development and biomanufacturing services that transition discoveries into early phase clinical trials. Recently, the facility has been working with industry partners to develop a COVID-19 vaccine and has produced a protein therapeutic to treat coronavirus patients that is currently in clinical testing.
Hensen joined BPDF as the facility project manager in September 2012. He previously served as the manager of performance and process optimization, manager of study toxicologists, and senior supervisor/toxicologist in the Early Development Group as a member of the Toxicology, Neurotoxicology, and Safety Testing team at Covance Laboratories Inc.
Hensen has more than 25 years of experience designing, conducting and monitoring drug development projects and building and leading teams for contract research and manufacturing organizations and their clients. He received a Bachelor of Science degree in biology with a business concentration from the University of Wisconsin-La Crosse, and is a trained Six Sigma Green Belt.
Submit a Story